WASHINGTON (AP) — Makers of medical tests that have long escaped government oversight will have about four years to show that their new offerings deliver accurate results, under a government rule vigorously opposed by the testing industry.
The regulation finalized Monday by the Food and Drug Administration will gradually phase in oversight of new tests developed by laboratories, a multibillion-dollar industry that regulators say poses growing risks to Americans. The goal is to ensure that new tests for cancer, heart disease, COVID-19, genetic conditions and many other illnesses are safe, accurate and reliable.
“The final rule announced today aims to provide crucial oversight of these tests to help ensure that important health care decisions are made based on test results that patients and health care providers can trust,” said FDA commissioner Robert Califf, in a release.
Supreme Court rejects an appeal from a Canadian man once held at Guantanamo
China's Xizang dubs 108 films into Tibetan language in 2023
Ningxia delicacies tempt int'l diners' palates
Seeing purple: Fans get a new track color and maybe record
Sweden beats France, Britain relegated after losing to Norway at hockey worlds
Musicians from Philadelphia Orchestra, Suzhou Symphony Orchestra stage chamber concert in Jiangsu
Chinese Culture and Technology Day held in Bulgaria
Tantalize your taste buds with Belt and Road cuisines!
Cruise worker 'murders newborn son on board ship': Shocked co
Guardians rally for 3 runs in 10th inning to stun Yankees 8
Candice Swanepoel stuns in a form
Fine arts students paint beautiful artworks in village in C China's Hubei